Abstract: The aim of this review is to determine the prevalence of PSA testing in primary care and the roles of family physicians in this matter, discuss benefits and harms of PSA testing and highlight some risk factors of prostate cancer. Comprehensive review was conducted using biomedical electronic databases such as; MEDLINE, and EMBASE, Science direct for all relevant articles published up to October, 2017. Primary care is the major setting where cancer is analyzed, or a minimum if it's assumed. Available documentation does not effectively reveal that PSA testing will certainly decrease prostate cancer death, however it accurately demonstrates a raised risk of harm. Lots of men see screening positively, however, are not aware of the possible harms. There is a visible need amongst family doctor for conclusive evidence on the equilibrium of testing advantages as well as dangers, any kind of use PSA screening to monitor for prostate cancer needs a thoughtful conversation between patient and doctor regarding the equilibrium in between significant risks and also uncertain advantages.
Keywords: Prostate cancer screening, PSA testing, prostate-specific antigen (PSA).
Title: Review of Evidence, Prostate Cancer Screening in Family Medicine
Author: Intithar Hussain Alherz, Laila Ibrahim Hussain Alhejji, Zahrah Ahmed Alyaseen, Amnah Ahmed Alhuwayji, Hanin Sami Bumozah, Zainab Abdulmajid Al-Mubarak, Sakinah Ibrahim Ali Alfadhel, Hawraa Radhi Alsuroj
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
